A patient has a positive test for hepatitis C and is admitted to the hospital. The admission laboratory tests reveal a normal ALT, and a liver biopsy is negative for hepatic fibrosis and in-flammation. The nurse will prepare this patient for:
a. dual therapy with pegylated interferon alfa and ribavirin.
b. no medication therapy at this time.
c. pegylated interferon alfa only until ALT levels are elevated.
d. triple drug therapy with pegylated inter-feron alfa, ribavirin, and boceprevir.
B
Current recommendations are that treatment is used only for patients with HCV viremia, persis-tent elevation of ALT, and evidence of hepatic fibrosis and inflammation upon liver biopsy. Dual therapy has been the regimen of choice for patients with the above symptoms, but the addition of a protease inhibitor has been shown to improve outcomes. It is not correct to give pegylated in-terferon alfa until ALT levels are elevated. Triple drug therapy is used for patients with the above symptoms.
You might also like to view...
When teaching the parents of a child with phenylketonuria, the nurse would instruct them to include which of the following foods in the child's diet?
A) Milk B) Oranges C) Meat D) Eggs
The nurse assesses the patient's nails and notes clubbing to the fingertips. The nurse recognizes this as a nail disorder common in patients who have:
A) Malnutrition B) Neurologic impairment C) Chronic respiratory impairment D) Renal insufficiency
Which of the following technologies does collaborative computing not use to achieve its goals?
1. E-mail and desktop videoconferencing 2. Digital libraries 3. Handheld devices 4. Shared databases
The nurse performs a sterile dressing change for a peripheral IV insertion site used for a continuous IV infusion. Which are potential nursing interventions for a sterile IV dressing change? (Select all that apply.)
1. Discontinue the IV infusion. 2. Apply a sterile gauze dressing. 3. Apply povidone-iodine solution. 4. Secure IV tubing to the dressing. 5. Cover with an occlusive dressing. 6. Tape hub over skin at insertion site.